BioScience Biz
News, commentary and analysis of the life sciences and the biotechnology business
About
See how we're connected
Categories
BioScience
Biotechnology
By Steven S. Clark
Commentary
Education
Entrepreneurs/Inventors
Ethics
Investing
IP
News
Pharma
Politics
Stem Cells
Wisconsin Technology Network - Biotech
Blogbar
Archives
November 2009
August 2009
July 2009
June 2009
May 2009
April 2009
February 2009
January 2009
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
Categories
BioScience
Biotechnology
By Steven S. Clark
Commentary
Education
Entrepreneurs/Inventors
Ethics
Investing
IP
News
Pharma
Politics
Stem Cells
More Information
RESOURCES
STEVE'S RESUME
Recent Posts
Cashing in on grant opportunities
FDA puts brakes on Geron stem cell trial--again
Researchers uncover possible link between avian flu and Parkinson's disease
STUDY SUGGESTS H1N1 VIRUS MORE DANGEROUS THAN SUSPECTED
VC funding is up for 2Q 2009
What’s new in stem cell research and therapy?
Is there an advantage to Angel vs VC backing during an IPO?
Making the transition from academia into the world of bioentrepreneurship
Is Alzheimer's caused by a presynaptic deficit in calcium mobilization?
SBIR Reauthorization—Déjà vu All Over Again
Subscribe in a reader
Subscribe to BioScience Biz by Email
Archives
November 2009
August 2009
July 2009
June 2009
May 2009
April 2009
February 2009
January 2009
November 2008
October 2008
More...